Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like <b>Nemaura Pharma</b> Secures Funding To Advance Its Micro-Patch Solid Dose Microneedle System For A Hormone Biologic February 6, 2017 It's Not Over Yet: Stays Mum on Plans for New Biotech Software Company April 12, 2017 CryoPort To Report Financial Results For The Three And Nine Months Ended December 31, 2016 On March 13th, 2017 March 1, 2017
<b>Nemaura Pharma</b> Secures Funding To Advance Its Micro-Patch Solid Dose Microneedle System For A Hormone Biologic February 6, 2017
CryoPort To Report Financial Results For The Three And Nine Months Ended December 31, 2016 On March 13th, 2017 March 1, 2017
